Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1987 2
1988 1
1989 5
1990 1
1991 2
1992 3
1993 4
1994 10
1995 15
1996 9
1997 12
1998 15
1999 11
2000 11
2001 9
2002 5
2003 15
2004 20
2005 26
2006 32
2007 37
2008 38
2009 41
2010 52
2011 36
2012 32
2013 32
2014 38
2015 44
2016 38
2017 16
2018 25
2019 28
2020 29
2021 47
2022 29
2023 22
2024 23
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

761 results

Results by year

Filters applied: . Clear all
Page 1
[Renal transplantation].
Rostaing L. Rostaing L. Nephrol Ther. 2017 Jun;13(6S):6S25-6S29. doi: 10.1016/S1769-7255(18)30037-3. Nephrol Ther. 2017. PMID: 29463396 Review. French.
Bis-Catecholamide-Based Materials for Uranium Extraction.
Mossand G, Lelong E, Xing C, Ndebulia Watchou F, Leydier A, Arrachart G, Pellet-Rostaing S. Mossand G, et al. Chempluschem. 2023 May;88(5):e202300103. doi: 10.1002/cplu.202300103. Epub 2023 Mar 9. Chempluschem. 2023. PMID: 36892187
Invited for this month's cover is the collaborating group of Dr Guilhem Arrachart and Dr Stephane Pellet-Rostaing at Institut de Chimie Separative de Marcoule (ICSM). The cover picture shows a person going uranium fishing thanks to the use of bis-catecholamide materials. . …
Invited for this month's cover is the collaborating group of Dr Guilhem Arrachart and Dr Stephane Pellet-Rostaing at Institut de Chim …
Adverse Drug Events after Kidney Transplantation.
Rostaing L, Jouve T, Terrec F, Malvezzi P, Noble J. Rostaing L, et al. J Pers Med. 2023 Dec 14;13(12):1706. doi: 10.3390/jpm13121706. J Pers Med. 2023. PMID: 38138933 Free PMC article. Review.
Renal complications of liver diseases.
Noble J, Jouve T, Malvezzi P, Rostaing L. Noble J, et al. Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1135-1142. doi: 10.1080/17474124.2018.1530984. Epub 2018 Oct 11. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30269605 Review.
Novel Approaches to Block Complement.
Böhmig GA, Wahrmann M, Eskandary F, Rostaing L. Böhmig GA, et al. Transplantation. 2018 Nov;102(11):1837-1843. doi: 10.1097/TP.0000000000002267. Transplantation. 2018. PMID: 29870459 Review.
Tailoring tacrolimus therapy in kidney transplantation.
Jouve T, Noble J, Rostaing L, Malvezzi P. Jouve T, et al. Expert Rev Clin Pharmacol. 2018 Jun;11(6):581-588. doi: 10.1080/17512433.2018.1479638. Epub 2018 May 25. Expert Rev Clin Pharmacol. 2018. PMID: 29779413 Review.
Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet.
Vincenti F, Budde K, Grinyo J, Rostaing L, Kirk AD, Larsen CP. Vincenti F, et al. Am J Transplant. 2023 Oct;23(10):1483-1484. doi: 10.1016/j.ajt.2023.05.033. Epub 2023 Jun 9. Am J Transplant. 2023. PMID: 37394381 Free article. No abstract available.
761 results